Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Hiemstra
MA26.06 Crizotinib-Treated ALK Immunopositive Metastasized NSCLC Is Associated With an Unfavorable Prognosis When FISH Negative
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-positive Advanced NSCLC Patient
Molecular and Clinical Oncology
Cancer Research
Oncology
P1.01-35 Tumor Volume Analysis in ALK-Rearranged NSCLC Treated With Crizotinib: Identifying an Early Marker for Clinical Outcome
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.13-04 Outcomes of ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With Crizotinib: A Multicenter Cohort Retrospective Study.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PIG3 Promotes NSCLC Cell Mitotic Progression and Is Associated With Poor Prognosis of NSCLC Patients
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-Generation ALK Inhibitor: A Monoinstitutional Experience
Oncotarget
Oncology
P1.01-30 Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients With ALK Rearrangement: A Retrospective Study and Literature Review
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Lower Blood Calcium Associates With Unfavorable Prognosis and Predicts for Bone Metastasis in NSCLC
PLoS ONE
Multidisciplinary
High LIFr Expression Stimulates Melanoma Cell Migration and Is Associated With Unfavorable Prognosis in Melanoma
Oncotarget
Oncology